XRCC2 and thyroid cancer: In a study conducted in Spain in the Caucasian population, analysis of the rs1799796 polymorphism (IVS7-14) did not show strong statistical associations with the risk of thyroid cancer, although a weak protective effect was suggested in combination with XRCC2 rs3218536 (Arg188His) [36].